Slipped Capital Femoral Epiphysis (SCFE)
Slipped Capital Femoral Epiphysis (SCFE) is a condition where the ball at the head of the femur slips off the neck of the bone, often causing hip pain and limited mobility.
We are testing whether tranexamic acid can reduce blood loss during hip surgeries in children. This study aims to see if it helps improve recovery and reduces the need for blood transfusions.
Health conditions and diseases that the clinical trial is designed to study and treat.
Slipped Capital Femoral Epiphysis (SCFE) is a condition where the ball at the head of the femur slips off the neck of the bone, often causing hip pain and limited mobility.
Legg-Calvé-Perthes Disease (LCPD) is a childhood condition that affects the hip joint, where the blood supply to the femoral head is temporarily disrupted, leading to pain and mobility issues.
Neuromuscular conditions are disorders that affect the muscles and the nerves that control them, leading to weakness and loss of muscle function.
Secondary hip dysplasia is a condition where the hip joint does not fit properly into the hip socket, often due to other underlying conditions or injuries.
Developmental Dysplasia of the Hip (DDH) is a condition where the hip joint is not formed properly in infants and young children, which can lead to dislocation and mobility issues.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.